Driehaus Capital Management’s Charles River Laboratories CRL Stock Holding History

Driehaus Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,200	Closed	-$7.71M	–	404
2023 Q1	$7.71M	Buy	+38,200	New	+$8.66M	0.11%	254
2016 Q4	–	Sell	-6,941	Closed	-$578K	–	550
2016 Q3	$578K	Sell	6,941 -2,059	-23%	-$173K	0.02%	418
2016 Q2	$742K	Buy	+9,000	New	+$741K	0.03%	380

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Driehaus Capital Management's CRL Position: Q2 2023 in Review

Driehaus Capital Management sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 38,200 shares — an estimated $7.71M sold.

Driehaus Capital Management first reported a position in CRL in Q2 2016 and held it in 3 quarters. The position peaked at $7.71M in Q1 2023. 611 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

Driehaus Capital Management reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
Driehaus Capital Management sold 38,200 Charles River Laboratories shares in Q2 2023, an estimated $7.71M.
Driehaus Capital Management first reported a position in Charles River Laboratories in Q2 2016 and held it in 3 quarters.
Driehaus Capital Management's Charles River Laboratories position peaked at $7.71M in Q1 2023.
611 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Driehaus Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.